Suramin and Suramin Analogues Inhibit Merozoite Surface Protein-1 Secondary Processing and Erythrocyte Invasion by the Malaria Parasite Plasmodium falciparum-Reference-Cited by-同舟云学术

Suramin and Suramin Analogues Inhibit Merozoite Surface Protein-1 Secondary Processing and Erythrocyte Invasion by the Malaria Parasite Plasmodium falciparum

Published:2003-11 Issue:48 Volume:278 Page:47670-47677
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Fleck Suzanne L.,Birdsall Berry,Babon Jeffrey,Dluzewski Anton R.,Martin Stephen R.,Morgan William D.,Angov Evelina,Kettleborough Catherine A.,Feeney James,Blackman Michael J.,Holder Anthony A.

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference36 articles.

1. Chemotherapy for Falciparum Malaria: The Armoury, the Problems and the Prospects

2. An Overview of Chemotherapeutic Targets for Antimalarial Drug Discovery

3. Proteins on the surface of the malaria parasite and cell invasion

4. Solution structure of an EGF module pair from the Plasmodium falciparum merozoite surface protein 1 1 1Edited by P. E. Wright

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plasmodium RNA triphosphatase validation as antimalarial target;International Journal for Parasitology: Drugs and Drug Resistance;2024-08

2. Effective factors in the pathogenesis of Toxoplasma gondii;Heliyon;2024-05

3. The bumpy road of purinergic inhibitors to clinical application in immune-mediated diseases;Neural Regeneration Research;2023-10-02

4. The role of invariant surface glycoprotein 75 in xenobiotic acquisition by African trypanosomes;Microbial Cell;2023-02-06

5. Antimalarial and Plasmodium falciparum serpentine receptor 12 targeting effect of FDA approved purinergic receptor antagonist;Journal of Biomolecular Structure and Dynamics;2022-11-09